Skip to main content
Premium Trial:

Request an Annual Quote

Tripos and Elsevier to Integrate Informatics Platforms

NEW YORK, Aug. 10 (GenomeWeb News) - Tripos and Elsevier MDL today said they plan to integrate their informatics platforms.


The two companies will now work to integrate the work-flow capabilities between Elsevier's MDL Isentris technology and Trips' Benchware suite of laboratory informatics software.


Under the terms of the agreement Tripos will now be a strategic member of the MDL Isentris Alliance, and Elsevier MDL will join the Tripos Alliance Program as a global strategic partner, the firms said.


Elsevier MDL CEO Lars Barfod said the alliance would facilitate "the integration of data and workflow between our products -- which is something that customers have been asking for."


Financial details were not disclosed.

The Scan

Not Immediately Told

The US National Institutes of Health tells lawmakers that one of its grantees did not immediately report that it had developed a more infectious coronavirus, Science says.

Seems Effective in Kids

The Associated Press reports that the Pfizer-BioNTech SARS-CoV-2 vaccine for children appears to be highly effective at preventing symptomatic disease.

Intelligence Warning on Bioeconomy Threats

US intelligence warns over China's focus on technologies and data related to the bioeconomy, the New York Times reports.

PLOS Papers on Campylobacteriosis Sources, Inherited Retinal Dystrophies, Liver Cancer Prognosis

In PLOS this week: approach to uncover source of Campylobacteriosis, genetic risk factors for inherited retinal dystrophies, and more.